Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Giglio

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
World Neurosurgery|May 26, 2019
Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic CorrelationDavid Dornbos, James B Elder, Jose J Otero, et al.
Plos One|December 29, 2020
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomasJoshua L Wang, Rolf F Barth, Robert Cavaliere, et al.
Journal of Neuro-Oncology|January 15, 2009
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomasJohn M Watkins, David T Marshall, Sunil Patel, et al.
Neuro-Oncology Advances|November 5, 2020
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Acta Neuropathologica Communications|December 4, 2023
Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differencesWesley Wang, Jonah Domingo Tugaoen, Paolo Fadda, et al.
Neuro-Oncology Advances|July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Acta Neuropathologica Communications|May 15, 2026
Dissecting acute neuronal responses to glioblastoma using a dual-interface human iPSC neuronal culture platformOuada Nebie, Niyi Adelakun, Brian Fries, et al.
The Neuroradiology Journal|January 30, 2023
Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival durationKristin Huntoon, Mina S Makary, Varun S Shah, et al.
Cancers|February 6, 2019
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A ReviewDenise Fabian, Maria Del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, et al.
Acta Neuropathologica Communications|April 11, 2025
Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastomaGlaucia Maria de Mendonça Fernandes, Wesley Wang, Saman Seyed Ahmadian, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
World Neurosurgery|May 26, 2019
Spinal Cord Toxicity from Intrathecal Chemotherapy: A Case with Clinicopathologic CorrelationDavid Dornbos, James B Elder, Jose J Otero, et al.
Plos One|December 29, 2020
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomasJoshua L Wang, Rolf F Barth, Robert Cavaliere, et al.
Journal of Neuro-Oncology|January 15, 2009
High-dose radiotherapy to 78 Gy with or without temozolomide for high grade gliomasJohn M Watkins, David T Marshall, Sunil Patel, et al.
Neuro-Oncology Advances|November 5, 2020
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Acta Neuropathologica Communications|December 4, 2023
Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differencesWesley Wang, Jonah Domingo Tugaoen, Paolo Fadda, et al.
Neuro-Oncology Advances|July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Acta Neuropathologica Communications|May 15, 2026
Dissecting acute neuronal responses to glioblastoma using a dual-interface human iPSC neuronal culture platformOuada Nebie, Niyi Adelakun, Brian Fries, et al.
The Neuroradiology Journal|January 30, 2023
Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival durationKristin Huntoon, Mina S Makary, Varun S Shah, et al.
Cancers|February 6, 2019
Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A ReviewDenise Fabian, Maria Del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, et al.
Acta Neuropathologica Communications|April 11, 2025
Epitranscriptomic analysis reveals clinical and molecular signatures in glioblastomaGlaucia Maria de Mendonça Fernandes, Wesley Wang, Saman Seyed Ahmadian, et al.
Pageof 10